PRAX Q2 2025 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$63M

Operating Income

-$76M

Net Income

-$71M

EPS (Diluted)

$-3.31

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$55M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$453M

Total Liabilities

$49M

Stockholders' Equity

$404M

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$357,000	-100.0%
Gross Profit	-$63M	-$27M	-134.2%
Operating Income	-$76M	-$37M	-102.9%
Net Income	-$71M	-$33M	-117.7%